China Pharma Holdings, Inc.
CPHIRating Trend
Earnings History
| Report Date | EPS Actual | EPS Est. | Revenue Actual | Revenue Est. |
|---|---|---|---|---|
| Aug 14, 2026 | $-0.04 | — | $948.3K | — |
| May 15, 2026 | $-0.04 | — | $983.5K | — |
| Apr 1, 2026 | $-0.18 | — | $1.2M | — |
| Nov 12, 2025 | $-0.17 | — | $756.2K | $756.2K |
| Aug 14, 2025 | $-0.16 | — | $1.0M | — |
| May 14, 2025 | $-0.24 | — | $1.1M | — |
| Mar 31, 2025 | $-0.50 | — | $1.1M | — |
| Nov 13, 2024 | $-0.60 | — | $1.1M | — |
News
MILAN--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, is expanding its drug development, manufacturing, and clinical capabilities to help pharmaceutical and biotechnology companies navigate increasingly complex paths to commercialization, reduce friction, and maintain momentum. The company will showcase these new and expanded capabilities at CPHI Milan 2026, Oct. 6-8. Among the new offerings is OSD Express, a defined solution designed to increase predictability.
CHASKA, Minn., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the CPHI Global Conference.